Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.
Hosted on MSN22h
Cantor Fitzgerald Upgrades Beam Therapeutics (BEAM)Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from Neutral to Overweight. Analyst Price Forecast Suggests 87.91% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback